Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Effects of Zeolite as a Drug Delivery System on Cancer Therapy: A Systematic Review (CROSBI ID 324878)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Hao, Jessica ; Stavljenić Milašin, Ivana ; Batu Eken, Zeynep ; Mravak-Stipetic, Marinka ; Pavelić, Krešimir ; Ozer, Fusun Effects of Zeolite as a Drug Delivery System on Cancer Therapy: A Systematic Review // Molecules, 26 (2021), 20; 6196, 33. doi: 10.3390/molecules26206196

Podaci o odgovornosti

Hao, Jessica ; Stavljenić Milašin, Ivana ; Batu Eken, Zeynep ; Mravak-Stipetic, Marinka ; Pavelić, Krešimir ; Ozer, Fusun

engleski

Effects of Zeolite as a Drug Delivery System on Cancer Therapy: A Systematic Review

Zeolites and zeolitic imidazolate frameworks (ZIFs) are widely studied as drug carrying nanoplatforms to enhance the specificity and efficacy of traditional anticancer drugs. At present, there is no other systematic review that assesses the potency of zeolites/ZIFs as anticancer drug carriers. Due to the porous nature and inherent pH-sensitive properties of zeolites/ZIFs, the compounds can entrap and selectively release anticancer drugs into the acidic tumor microenvironment. Therefore, it is valuable to provide a comprehensive overview of available evidence on the topic to identify the benefits of the compound as well as potential gaps in knowledge. The purpose of this study was to evaluate the potential therapeutic applications of zeolites/ZIFs as drug delivery systems delivering doxorubicin (DOX), 5-fluorouracil (5-FU), curcumin, cisplatin, and miR-34a. Following PRISMA guidelines, an exhaustive search of PubMed, Scopus, Embase, and Web of Science was conducted. No language or time limitations were used up to 25th August 2021. Only full text articles were selected that pertained to the usage of zeolites/ZIFs in delivering anticancer drugs. Initially, 1279 studies were identified, of which 572 duplicate records were excluded. After screening for the title, abstract, and full texts, 53 articles remained and were included in the qualitative synthesis. An Inter-Rater Reliability (IRR) test, which included a percent user agreement and reliability percent, was conducted for the 53 articles. The included studies suggest that anticancer drug-incorporated zeolites/ZIFs can be used as alternative treatment options to enhance the efficacy of cancer treatment by mitigating the drawbacks of drugs under conventional treatment.

zeolite ; clinoptilolite ; zeolitic imidazolate framework ; metal-organic framework ; cancer therapy ; nanocarrier ; anticancer drug ; antineoplastic drug ; drug delivery system ; systematic review

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

26 (20)

2021.

6196

33

objavljeno

1420-3049

10.3390/molecules26206196

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost